IP Library › Assignment 043341/0519
Patent Assignment
Reel/Frame 043341/0519

Change of Name

Recorded: 2017-07-26 Pages: 4
Assignor
ISIS PHARMACEUTICALS, INC.
Executed: 2015-12-18
Assignee
IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT, CARLSBAD, CALIFORNIA, 92010
Covered Properties (10)
Trpm-2 Antisense Therapy
Patent: 7,534,773 →
Application: 09/913,325 →
Antisense Modulation of Helicase-Moi Expression
Patent: 7,427,470 →
Application: 10/160,632 →
Publication: US 2003/0176380
Oligoribonucleotides and Ribonucleases for Cleaving Rna
Patent: 7,432,250 →
Application: 10/281,312 →
Publication: US 2003/0096287
Pulsatile Release Compositions and Methods for Enhanced Intestinal Oligonucleotide Drug Absorption
Patent: 7,576,067 →
Application: 11/000,814 →
Publication: US 2005/0196443
Human Rnase Iii and Compositions and Uses Thereof
Patent: 7,491,524 →
Application: 11/001,993 →
Publication: US 2005/0159384
Compounds and Methods for the Characterization of Oligonucleotides
Patent: 7,427,675 →
Application: 11/209,160 →
Publication: US 2006/0040308
6-Modified Bicyclic Nucleic Acid Analogs
Patent: 7,399,845 →
Application: 11/627,964 →
Publication: US 2007/0249049
Methods for Detection of Chloral Hydrate in Dichloroacetic Acid
Patent: 7,446,193 →
Application: 11/670,283 →
Publication: US 2007/0196847
Compounds and Methods for Synthesis of Bicyclic Nucleic Acid Analogs
Patent: 7,569,686 →
Application: 11/747,042 →
5'-Modified Bicyclic Nucleic Acid Analogs
Patent: 7,547,684 →
Application: 11/747,057 →
Publication: US 2007/0287831
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement Sep 27, 2016
From: FOUNDATION MEDICINE, INC.
To: ROCHE FINANCE LTD
Reel/Frame 040165/0615 →
Release of Security Interest Jun 30, 2021
From: ROCHE FINANCE LTD
To: FOUNDATION MEDICINE, INC.
Reel/Frame 056715/0711 →